Document Detail

Astrocytes derived from fetal neural progenitor cells as a novel source for therapeutic adenosine delivery.
MedLine Citation:
PMID:  20688264     Owner:  NLM     Status:  MEDLINE    
PURPOSE: Intracerebral delivery of anti-epileptic compounds represents a novel strategy for the treatment of refractory epilepsy. Adenosine is a possible candidate for local delivery based on its proven anti-epileptic effects. Neural stem cells constitute an ideal cell source for intracerebral transplantation and long-term drug delivery. In order to develop a cell-based system for the long-term delivery of adenosine, we isolated neural progenitor cells from adenosine kinase deficient mice (Adk(-/-)) and compared their differentiation potential and adenosine release properties with corresponding wild-type cells.
METHODS: Fetal neural progenitor cells were isolated from the brains of Adk(-/-) and C57BL/6 mice fetuses and expanded in vitro. Before and after neural differentiation, supernatants were collected and assayed for adenosine release using liquid chromatography-tandem mass spectrometry (LC-MS/MS).
RESULTS: Adk(-/-) cells secreted significantly more adenosine compared to wild-type cells at any time point of differentiation. Undifferentiated Adk(-/-) cells secreted 137+/-5 ng adenosine per 10(5) cells during 24 h in culture, compared to 11+/-1 ng released from corresponding wild-type cells. Adenosine release was maintained after differentiation as differentiated Adk(-/-) cells continued to release significantly more adenosine per 24 h (47+/-1 ng per 10(5) cells) compared to wild-type cells (3+/-0.2 ng per 10(5) cells).
CONCLUSIONS: Fetal neural progenitor cells isolated from Adk(-/-) mice--but not those from C57BL/6 mice--release amounts of adenosine considered to be of therapeutic relevance.
Annelies Van Dycke; Robrecht Raedt; Alain Verstraete; Panos Theofilas; Wytse Wadman; Kristl Vonck; Detlev Boison; Paul Boon
Related Documents :
10328944 - Imaging cells in the developing nervous system with retrovirus expressing modified gree...
15259034 - Developmental consequences of abnormal folate transport during murine heart morphogenesis.
8457874 - Differentiation of neurogenic precursors within the neural crest cell lineage.
9136804 - Role of nonrandomly oriented cell division in shaping and bending of the neural plate.
2832864 - Molecular rearrangements between two plasmids of the fii incompatibility group in diffe...
79514 - Specific cell-induced transformation of paramecium surface antigens.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2010-06-17
Journal Detail:
Title:  Seizure : the journal of the British Epilepsy Association     Volume:  19     ISSN:  1532-2688     ISO Abbreviation:  Seizure     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-06     Completed Date:  2010-12-02     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  9306979     Medline TA:  Seizure     Country:  England    
Other Details:
Languages:  eng     Pagination:  390-6     Citation Subset:  IM    
Copyright Information:
2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Laboratory for Clinical and Experimental Neurophysiology, Department of Neurology, Ghent University Hospital, 1K12, 185 De Pintelaan, 9000 Ghent, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adenosine / administration & dosage*
Adenosine Kinase / deficiency,  genetics
Astrocytes / cytology,  metabolism,  transplantation*
Blotting, Western
Cell Differentiation
Chromatography, Liquid
Epilepsy / drug therapy*
Fetal Stem Cells / cytology,  metabolism,  transplantation*
Injections, Intraventricular
Mass Spectrometry
Mice, Inbred C57BL
Mice, Knockout
Polymerase Chain Reaction
Stem Cell Transplantation / methods*
Grant Support
MH083973/MH/NIMH NIH HHS; NS057475/NS/NINDS NIH HHS; NS057538/NS/NINDS NIH HHS; NS058780/NS/NINDS NIH HHS; NS061844/NS/NINDS NIH HHS; R01 MH083973/MH/NIMH NIH HHS; R01 MH083973-02/MH/NIMH NIH HHS; R01 MH083973-03/MH/NIMH NIH HHS; R01 MH083973-04/MH/NIMH NIH HHS; R01 NS058780-03/NS/NINDS NIH HHS; R01 NS058780-04/NS/NINDS NIH HHS; R01 NS061844/NS/NINDS NIH HHS; R01 NS061844-02/NS/NINDS NIH HHS; R01 NS061844-03/NS/NINDS NIH HHS; R01 NS061844-04/NS/NINDS NIH HHS; R21 NS057475-01A2/NS/NINDS NIH HHS; R21 NS057538-01A2/NS/NINDS NIH HHS
Reg. No./Substance:
58-61-7/Adenosine; EC Kinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Fish oil supplementation increases the cyclooxygenase inhibitory activity of paracetamol in rheumato...
Next Document:  [Identity of gender and intensive care: influence of masculinity and femininity in the perception of...